Once inside, the virion reprograms the genetic material of the immune cell to produce more HIV virions. In this way, HIV disables the disease-fighting 'bodyguards' in our blood and turns them into ...

Recent discoveries about the way that HIV infects cells are propelling the development of a broad spectrum of promising new antiviral drugs, according to an invited commentary on the topic in the ...

An interdisciplinary team of scientists from KU Leuven in Belgium has developed a new technique to examine how proteins interact with each other at the level of a single HIV viral particle. The ...

Once inside, the virion reprograms the genetic material of the immune cell to produce more HIV virions. In this way, HIV disables the disease-fighting 'bodyguards' in our blood and turns them into ...

Duel to the Death Inside HIV-Infected Cells. Discovery of Shadowy Enzyme and Its Nemesis May Prove Key Step in Defeating the Virus That Causes AIDS. March 8, 2004. By David Brown.

While HIV cell-to-cell transmission has been observed in test tube experiments, this is the first study to capture these interactions in a living animal. Although cell-to-cell infection does ...

The National Institutes of Health has awarded over $8 million to the Texas Biomedical Research Institute to collaborate with a company in Switzerland to study a vaccine to protect against HIV ...

By contrast, the HIV virion was known to have an asymmetrical form, and it has also been established that many viruses have some variance in the stable structures they can assume.

When HIV enters the cell, the bond formed between LIF and its receptor prompts the release of other, ... Virion, a biotechnology company in Michigan, holds a patent on HIV-related uses of LIF.

"All HIV treatment to date has been based on the free-floating virion model," says Benjamin K. Chen, MD, PhD, an Associate Professor of Infectious Diseases, Microbiology, and Immunology at the ...